CIK 0001671858 · Non-accelerated filer<br>Smaller reporting company
ARS Pharmaceuticals, Inc.
Sign in to watch- Ticker
- SPRY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 811489190
- Phone
- 858-771-9307
- Business address
- 11682 EL CAMINO REAL, SUITE 300, SAN DIEGO, CA, 92130
- Former names
- Silverback Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-02 | Chakma Justin Chief Business Officer | Grant or award · Stock option (right to buy) | +240,000 | 240,000 | ||
| 2026-01-02 | Scott Kathleen D. Chief Financial Officer | Grant or award · Stock option (right to buy) | +240,000 | 240,000 | ||
| 2026-01-02 | Fitzpatrick Alexander A Chief Legal Officer | Grant or award · Stock option (right to buy) | +240,000 | 240,000 | ||
| 2026-01-02 | Dorsey Brian Chief Operating Officer | Grant or award · Stock option (right to buy) | +240,000 | 240,000 | ||
| 2026-01-02 | Lowenthal Richard E PRESIDENT AND CEO | Grant or award · Stock option (right to buy) | +875,000 | 875,000 | ||
| 2026-01-02 | Lowenthal Richard E PRESIDENT AND CEO | Grant or award · Stock Option (right to buy) | +240,000 | 240,000 | ||
| 2025-11-13 | Dorsey Brian Chief Operating Officer | Option exercise | +21,828 | $0.64 | $14K | 32,617 |
| 2025-11-13 | Dorsey Brian Chief Operating Officer | Sale | −21,828 | $8.71 | $190K | 10,789 |
| 2025-11-13 | Dorsey Brian Chief Operating Officer | Option exercise · Stock Option (Right to Buy) | −21,828 | 0 | ||
| 2025-11-12 | Chakma Justin Chief Business Officer | Option exercise | +30,000 | $0.84 | $25K | 166,380 |
| 2025-11-12 | Chakma Justin Chief Business Officer | Sale | −30,000 | $8.91 | $267K | 136,380 |
| 2025-11-12 | Chakma Justin Chief Business Officer | Sale | −136,380 | $8.86 | $1.2M | 0 |
| 2025-11-12 | Chakma Justin Chief Business Officer | Option exercise · Stock Option (Right to Buy) | −30,000 | 89,047 | ||
| 2025-11-12 | Shah Pratik Director | Gift | −250,000 | 4,574,554 | ||
| 2025-11-12 | Shah Pratik Director | Gift | −100,000 | 4,474,554 | ||
| 2025-08-21 | Lowenthal Richard E PRESIDENT AND CEO | Sale 10b5-1 | −50,000 | $14.49 | $724K | 1,196,494 |
| 2025-08-21 | Scott Kathleen D. Chief Financial Officer | Option exercise 10b5-1 | +12,500 | $1.50 | $19K | 22,542 |
| 2025-08-21 | Scott Kathleen D. Chief Financial Officer | Sale 10b5-1 | −12,500 | $15.00 | $188K | 10,042 |
| 2025-08-21 | Scott Kathleen D. Chief Financial Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −12,500 | 739,830 | ||
| 2025-08-20 | Tanimoto Sarina CHIEF MEDICAL OFFICER | Sale 10b5-1 | −37,656 | $14.09 | $531K | 1,247,447 |
Page 2 of 14 · 267 trades